EPAT General Discussion, page-63

This thing is behaving just like SAS and RAP did, slow to launch and then just when you think you should start trading for a few pips the bag runs begin and people go oh yeah that was always going to happen...

The facts here are pretty compelling:

The product has proven to be superior to existing pain identification methods
The addressable market is a multi-billion dollar market
We have industry support from companies that will purchase the end product
We have a clear and fast pathway to commercialization (this year)
Clear indications have been made by both EPT management, IBM and nViso that there will be other verticals introduced.

As other have eluded to we have the RTO curse to overcome and as such may need to churn out a few more stale holders before this is allowed to rerate properly however once it does tip the scale the movements could be expected to be quite spectacular. RAP ran fron 2-13c inside 10 weeks. SAS done a similar run in 7 weeks.

EPT have mentioned a target commercialization by November this year, 30 weeks away...